{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T11:10:56Z","timestamp":1779880256230,"version":"3.53.1"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"24","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Hemophilia A (HA) is an X-linked recessive disorder caused by clotting factor VIII (FVIII) deficiency. There is limited data on the use of replacement therapy in cardiac surgery. Since no international guideline for anticoagulation in such patient exists, careful thought should be taken to design an individualized anticoagulation strategy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>We report a 54-year-old male with severe HA with FVIII activity of 0.8% when he was first diagnosed, who underwent successful mitral valve repair and coronary artery bypass graft with FVIII replacement perioperatively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>Transthoracic echocardiography and coronary angiography confirmed the HA patient with the diagnosis of severe mitral valve regurgitation and left anterior descending artery stenosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>Before surgery, a bolus of 1000 IU FVIII was injected, which obtained an FVIII of 80%. After induction, a 3750 IU bolus of FVIII was injected and subsequent FVIII level reached 135%. Mitral valve repair and coronary artery bypass graft with FVIII replacement were performed. After the surgery, a repeat FVIII activity level was 50.6%. The 400 mL of autologous blood and 700 mL of cardiopulmonary bypass (CPB) machine blood was returned to the patient as well as 4 units of fresh frozen plasma with an additional bolus of 1000 IU FVIII. 100\u200amg aspirin per day alone was given after surgery.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The patient recovered uneventfully and 1-year follow-up showed no complications.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>The anticoagulant or antiplatelet regimen of HA patient following surgery should be individualized based on the evaluation of the risk factors for bleeding and thrombosis and the lowest FVIII activity ever recorded after FVIII replacement therapy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000015897","type":"journal-article","created":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T08:53:40Z","timestamp":1560416020000},"page":"e15897","source":"Crossref","is-referenced-by-count":10,"title":["Peri-cardiac surgery coagulation management in a severe hemophilia A patient"],"prefix":"10.1097","volume":"98","author":[{"given":"Hongfei","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Cardiothoracic Surgery"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davies","family":"Henry","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengcheng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haige","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of pharmacy, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230914","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/jocs.13530","article-title":"Replacement therapy for coronary artery bypass surgery in patients with hemophilia A and B","volume":"33","author":"Kanellopoulou","year":"2018","journal-title":"J Card Surg"},{"key":"R2-20230914","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1177\/1089253217702747","article-title":"Perioperative coagulation management of a hemophilia a patient during cardiac surgery","volume":"21","author":"Odonkor","year":"2017","journal-title":"Semin Cardiothorac Vasc Anesth"},{"key":"R3-20230914","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1160\/TH12-05-0332","article-title":"Unfavourable cardiovascular disease risk profiles in a cohort of Dutch and British haemophilia patients","volume":"109","author":"Fransen van de Putte","year":"2013","journal-title":"Thromb Haemost"},{"key":"R4-20230914","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1161\/CIR.0000000000000182","article-title":"Secondary prevention after coronary artery bypass graft surgery: a scientific statement from the American Heart Association","volume":"131","author":"Kulik","year":"2015","journal-title":"Circulation"},{"key":"R5-20230914","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2516.2008.01895.x","article-title":"Cardiac surgery in patients with haemophilia","volume":"15","author":"Tang","year":"2009","journal-title":"Haemophilia"},{"key":"R6-20230914","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1097\/00003643-200412000-00011","article-title":"Continuous infusion of factor VIIIc during heart surgery in a patient with haemophilia A","volume":"21","author":"De Bels","year":"2004","journal-title":"Eur J Anaesthesiol"},{"key":"R7-20230914","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2516.2006.01283.x","article-title":"Use of factor VIII replacement during open heart surgery in a patient with haemophilia A","volume":"12","author":"Stine","year":"2006","journal-title":"Haemophilia"},{"key":"R8-20230914","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.athoracsur.2010.10.077","article-title":"Hemophilia A in cardiac operations: a model of reduced thrombin generation","volume":"91","author":"Lison","year":"2011","journal-title":"Ann Thorac Surg"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201906140-00018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T16:41:12Z","timestamp":1694709672000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201906140-00018"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":8,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000015897","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6]]}}}